Metabolomic signatures of data-driven type 2 diabetes subtypes and their associations with dementia and stroke risk

More on Type 2 diabetes

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• GLP-1 agonists linked to lower dementia risk after COVID-19

  Drug Design, Development and Therapy · 5 Oct 2026

  

• APOE disease risks and proteomic links vary by ancestry

  medRxiv · 4 Oct 2026